Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion type Assertion NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_head.
- NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion description "[However, oncogenic transforming PIK3CA mutations have been shown to predict a better outcome in ER+/HER2-negative BC treated with endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_provenance.
- NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion evidence source_evidence_literature NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_provenance.
- NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion SIO_000772 24011769 NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_provenance.
- NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion wasDerivedFrom befree-20150227 NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_provenance.
- NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_assertion wasGeneratedBy ECO_0000203 NP621755.RA7oPTVISdrCXz2jdYlRYcG6f1yUdke_ZnqkyqWGtp_Gs130_provenance.